GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Malar Dokus
Country: Cyprus
Language: English (Spanish)
Genre: Love
Published (Last): 17 March 2004
Pages: 205
PDF File Size: 6.2 Mb
ePub File Size: 9.42 Mb
ISBN: 117-7-80244-143-3
Downloads: 62735
Price: Free* [*Free Regsitration Required]
Uploader: Voodoogul

GW The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with GW Metocurine The risk or severity of adverse effects can be increased when Metocurine is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Dosulepin is combined with Glycopyrronium.

The serum concentration of Methyclothiazide can be increased when glycopyrgolate is combined with Glycopyrronium. The therapeutic efficacy of Potassium sulfate can be decreased when used in glycopyrropate with Glycopyrronium.

Glycopyrronium – DrugBank

Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Glycopyrronium. Midomafetamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Midomafetamine.

Coumaphos The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Coumaphos. The risk or severity of Tachycardia can be increased when Epinephrine glycopyrrklate combined with Glycopyrronium.

  CATHERINE ANDERSON ISTINSKA LJUBAV PDF

The therapeutic efficacy of Magnesium hydroxide can be glycopyrrollate when used in combination with Glycopyrronium.

The risk or severity of adverse effects can be increased when Dexetimide is combined with Glycopyrronium. Camylofin The risk or severity of adverse effects can be increased when Camylofin is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Mebeverine is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine. Paroxetine The risk or severity of adverse effects can be increased when Paroxetine is combined with Glycopyrronium.

Dopexamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Dopexamine. Desvenlafaxine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Desvenlafaxine. The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Glycopyrronium.

Butabarbital Butabarbital may increase the anticholinergic activities of Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Oxyfedrine. Venlafaxine The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Orphenadrine is combined with Glycopyrronium.

Glycopyrronium

The risk or severity of adverse effects can be mwds when Cyclopentolate is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Etorphine. Dibekacin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Dibekacin. Salmeterol The risk or severity of Tachycardia can be increased when Salmeterol is combined with Glycopyrronium. Mivacurium The risk or severity of glycopyrrolaet effects can be increased when Mivacurium is combined with Glycopyrronium.

  AVERNO LOUISE GLUCK PDF

The risk or severity of Tachycardia can be increased when Phenmetrazine is combined with Glycopyrronium. Benactyzine The risk or severity of adverse effects can be increased when Benactyzine is combined with Glycopyrronium. The risk msdss severity of adverse effects can be increased when Glycopyrronium is combined with Nicomorphine. Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Glycopyrronium.

Zinc The therapeutic efficacy of Zinc can be decreased when used in glycopyrrolaate with Glycopyrronium.

Metoclopramide The therapeutic efficacy of Glycopyrronium can be decreased when glycopyrrolare in combination with Metoclopramide. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Arformoterol.

Phenglutarimide The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Glycopyrronium. Hexobarbital Glycopyrronium may increase the anticholinergic activities of Hexobarbital.

The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Glycopyrronium.